COMMUNIQUÉS West-GlobeNewswire

Nexstim Plc's Financial Information in 2018

13/12/2017 - 08:01

Company announcement, Helsinki, 13 December 2017, at 9 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or the " Company "), a medical technology company developing and marketing pioneering navigated non-invasive [...]

Sanofi : Sanofi presents R&D strategy and innovative pipeline

13/12/2017 - 07:16

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi presents R&D strategy and innovative pipeline · Robust pipeline expected to support long-term growth · 9 planned regulatory submissions over next 18 [...]

Sanofi : Sanofi présente sa stratégie de R&D et son portefeuille innovant

13/12/2017 - 07:16

Sanofi présente sa stratégie de R&D et son portefeuille innovant · Un portefeuille robuste qui devrait soutenir la croissance à long terme · Neuf soumissions réglementaires planifiées au cours des 18 prochains mois [...]

Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma

13/12/2017 - 07:02

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma High and durable [...]

Sanofi et Regeneron annoncent les premiers résultats positifs d'une étude pivot consacrée à l'anticorps anti-PD-1 cemiplimab dans le traitement du carcinome épidermoïde cutané au stade avancé

13/12/2017 - 07:02

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi et Regeneron annoncent les premiers résultats positifs d'une étude pivot consacrée à l'anticorps anti-PD-1 cemiplimab dans le traitement du [...]

Targovax to present at DNB healthcare conference

13/12/2017 - 07:00

Oslo, Norway, 13 December 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that members of its senior management will present a [...]

Resverlogix Announces Voting Results From The 2017 Annual Meeting Of Shareholders

13/12/2017 - 02:08

CALGARY, Alberta, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX: RVX ) announced today that, at its annual meeting of shareholders held on December 12, 2017, Resverlogix [...]

House and Senate Agree: Palliative Care Matters!

12/12/2017 - 23:30

Surrey, BC, Canada, Dec. 12, 2017 (GLOBE NEWSWIRE) -- (Dec 12, 2017) In a time when House and Senate don’t always agree – it is refreshing that both groups voted “yes” to federal legislation to develop a framework for [...]

Dentsply Sirona Declares Quarterly Cash Dividend

12/12/2017 - 23:00

YORK, Pa., Dec. 12, 2017 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company TM , announced that its Board of Directors declared a quarterly cash dividend of $0. [...]

Telix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing Partnership

12/12/2017 - 23:00

MELBOURNE, Australia and TOKYO, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“ Telix ”, the “ Company ”), an Australian biopharmaceutical company focused on the development of diagnostic [...]

The Cooper Companies to Present at J.P. Morgan Healthcare Conference

12/12/2017 - 22:19

PLEASANTON, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) will present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on January 9, 2018. Robert S. Weiss, [...]

Burcon NutraScience Announces Receipt of NASDAQ Letters Regarding Delisting and Deficiency in Compliance With Certain Listing Rules

12/12/2017 - 22:14

VANCOUVER, British Columbia, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Company”), a leader in developing functionally and nutritionally valuable plant- [...]

Denali Therapeutics Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

12/12/2017 - 22:10

SOUTH SAN FRANCISCO, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI ) today announced the closing of its initial public offering of 15,972,221 shares of its common stock at a price to [...]

Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock

12/12/2017 - 22:02

CAMBRIDGE, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (Nasdaq: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]

Brainsway Raises $8.5 Million From Leading Israeli Investors

12/12/2017 - 22:01

Phoenix Group becomes 7% shareholder Financing strengthens Brainsway's balance sheet and provides strong support for continued growth HACKENSACK, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE: BRIN ), a [...]

Fennec Announces Closing of Public Offering

12/12/2017 - 22:01

RESEARCH TRIANGLE PARK, N.C., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC ) (TSX: FRX ), a biotechnology company focused on the development of PEDMARK™ (a unique formulation of sodium [...]

Tabula Rasa HealthCare Named Best Performing IPO Among Top 50 Digital Health Companies in 2017

12/12/2017 - 21:29

MOORESTOWN, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare technology company advancing the field of medication safety, was named by Rock Health as the best [...]

How to Care for Children With Chickenpox; American Academy of Dermatology

12/12/2017 - 20:10

SCHAUMBURG, Ill., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Chickenpox is a highly contagious disease caused by a virus. Although the incidence of chickenpox has declined significantly since the development of the chickenpox [...]

Tauriga Sciences, Inc. Fully Repays $35,000 8% Face Value Convertible Debenture Issued to Eagle Equities, LLC during June of 2017 for One Time Cash Payment of $50,015.75 USD

12/12/2017 - 19:20

NEW YORK, NY, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building business through the development, distribution, and licensing of proprietary [...]